NDTV News

Lupin Q1 Review: Dolat Capital Maintains 'Add', But Cuts Target Price - Here's Why

Timely launches of injectables and inhalation products will be further triggers to the brokerage's earnings estimates.

adminadmin
Aug 7, 2025 - 15:00
 0  17
Lupin Q1 Review: Dolat Capital Maintains 'Add', But Cuts Target Price - Here's Why
Timely launches of injectables and inhalation products will be further triggers to the brokerage's earnings estimates.
Read More

Tags:

Previous Article

Emkay's Manish Sonthalia Not Worried, Expects Trump's Tariffs To Come Down

Next Article

Sumadhura Group Rents Out Commercial Spaces In Bengaluru For Rs 50 Crore Per Year

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

admin
admin

Related Posts

South Eastern Coalfields Hiring For 800 Posts, No Written Test Or Interview Required

South Eastern Coalfields Hiring For 800 Posts, No Writt...

admin Feb 8, 2025  0  20

"Even If It Means Merging PoK...": Revanth Reddy To PM Modi On J&K Attack

"Even If It Means Merging PoK...": Revanth Reddy To PM ...

admin Apr 26, 2025  0  30

Asia Cup LIVE: Bangladesh Shock 4-Down Afghanistan Agai...

admin Sep 17, 2025  0  174